Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing RequirementsSEATTLE, March 18, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ( Atossa or the Company ), today announced that on March 15, 2024, the Company received written notice from...
Globe Newswire•4 months ago